DYNLL2 divergent transcript (DYNLL2-DT)

DYNLL2 divergent transcript (DYNLL2-DT) refers to a transcript from the DYNLL2 locus that does not appear to code for a protein[5]. The DYNLL2 gene itself encodes the dynein light chain LC8-type 2, a conserved eukaryotic hub protein with diverse cellular roles, but DYNLL2-DT is annotated as a divergent transcript, which typically denotes a non-coding RNA transcribed from a region adjacent to the canonical gene. There are no known biological functions, disease roles, or therapeutic applications associated with DYNLL2-DT, nor are there reported drug interactions, safety issues, or biomarker utility for patient selection or monitoring. No substantial research or evidence identifies this transcript as a receptor, enzyme, transporter, or other classical therapeutic target. The term DYNLL2-DT itself is most often found in gene annotation databases, such as NCBI Gene and BioGPS, but detailed functional or disease linkage information is not currently available[5]. The query concerns DYNLL2 divergent transcript (DYNLL2-DT). There is no evidence it functions as a receptor, enzyme, transporter, or any classic therapeutic target. Most research and clinical interest focuses on the DYNLL2 gene (dynein light chain LC8-type 2), not the divergent transcript. The use of "DYNLL2-DT" as a therapeutic target is incorrect based on available data; there are no validated biological functions or clinical associations for this transcript[5].

Other names

DYNLL2-DTDYNLL2 divergent transcript

Not applicable